Clinical Trials · NCT07569315

Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders

Name: Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Not Yet RecruitingPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Not Yet Recruiting
Sponsor: Bedaya Hospital
Enrollment: 190
Start date: Jun 2026
Locations: 1 site, Egypt
Primary endpoint: Metaphase-II oocytes rate

View Gonadorelin compound reference